Symptomatic hyponatremia during glomerular filtration rate testing

Hyponatremia affects nearly one in five of all hospitalized patients. Severe hyponatremia is associated with significant morbidity and mortality, and is therefore important to recognize. Prior reports have linked duloxetine with hyponatremia, but it is uncommon. In this case report, we describe a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Balaram, Manjunath, Ford, Virginia, Townsend, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421406/
https://www.ncbi.nlm.nih.gov/pubmed/25949461
http://dx.doi.org/10.1093/ndtplus/sfq166
Descripción
Sumario:Hyponatremia affects nearly one in five of all hospitalized patients. Severe hyponatremia is associated with significant morbidity and mortality, and is therefore important to recognize. Prior reports have linked duloxetine with hyponatremia, but it is uncommon. In this case report, we describe a research subject taking duloxetine who developed severe symptomatic hyponatremia during glomerular filtration rate testing despite having undergone such testing uneventfully in the past.

Ejemplares similares